TY  - RPRT
TI  - Robust Preclinical Evidence in Somatic Cell Genome Editing: A Key Driver of Responsible and Efficient Therapeutic Innovations
AU  - Bittlinger, M.
AU  - Schwietering, J.
AU  - Strech, D.
PY  - 2020
DO  - 10.1101/2020.09.09.290338
UR  - https://www.biorxiv.org/content/10.1101/2020.09.09.290338v1
ID  - 10.1101/2020.09.09.290338
ER  -